Jakub Knurek is a marketing and business development expert specializing in CDMO operations with scientific and biopharmaceutical background. During the COVID-19 pandemic, he contributed to the development of the Novavax protein vaccine. As a side project, he runs his own pharma company.As the author of numerous articles, he is recognized as an important voice of the younger generation of scientists. He is a member of Mabion's representation at industry trade shows, including BIO International Convention 2025 in Boston, 2nd Global Biologics India 2025 in Hydrabad, CPHI 2024 in Milan, CPHI 2023 in Barcelona, Life Sciences Baltics 2023 in Vilnius. He actively participates in academic, business and industry discussions, such as the “Building the Future Pharma Workforce” panel at CPHI Milan 2024.
Articles
How Mabion Builds Space for Women in Biopharma
Quality Control of Biologics Ensuring Safety Through Aggregation Analysis
Analytics, Biologics, GMP, Proteins
Co-Development Partnership Models in Biologics Programs
Biologics, Drug development, Mabion, Partnership
ADC Manufacturing – A Comprehensive Guide to Drug Substance Manufacturing Services
Antibody-drug conjugates, GMP, Manufacturing
Mentoring program supports industry–academia collaboration
Bioprocess Scale-Up from Lab Scale to Commercial GMP Manufacturing
Clinical trials, GMP, Manufacturing